AbbVie Reports First-Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
AbbVie (ABBV) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
April 29, 2026 7:48 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $2.65, $0.06 better than the analyst estimate of $2.59. Revenue for the quarter came in at $15 billion versus the consensus estimate of $14.73 billion.
GUIDANCE:
AbbVie sees FY2026 EPS of $14.08-$14.28, versus the consensus of $14.21.
For earnings history and earnings-related data on AbbVie (ABBV) click here.
... More